The Current Ratio as of December 2025 (TTM) for Calidi Biotherapeutics, Inc. (CLDI) is 2.12

According to Calidi Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.12. This represents a change of 31.74% compared to the average of 1.61 of the last 4 quarters.

Calidi Biotherapeutics, Inc. (CLDI) Historical Current Ratio (quarterly & annually)

How has CLDI Current Ratio performed in the past?

The mean historical Current Ratio of Calidi Biotherapeutics, Inc. over the last ten years is 0.33. The current 2.12 Current Ratio has changed 65.01% with respect to the historical average. Over the past ten years (40 quarters), CLDI's Current Ratio was at its highest in in the September 2021 quarter at 41.86. The Current Ratio was at its lowest in in the March 2023 quarter at 0.04.

Calidi Biotherapeutics, Inc. (CLDI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Calidi Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Calidi Biotherapeutics, Inc. (CLDI) Average Current Ratio

How has CLDI Current Ratio performed in the past?

The current Current Ratio of Calidi Biotherapeutics, Inc. (CLDI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Calidi Biotherapeutics, Inc. (CLDI) Current Ratio vs. Peers

How is CLDI’s Current Ratio compared to its peers?

Calidi Biotherapeutics, Inc.’s Current Ratio is greater than Clearmind Medicine Inc. (1.74), less than Can-Fite BioPharma Ltd. (3.60), greater than Kazia Therapeutics Limited (0.21), less than Titan Pharmaceuticals, Inc. (11.60), less than Silo Pharma, Inc. (8.70), less than CNS Pharmaceuticals, Inc. (5.81), less than 60 Degrees Pharmaceuticals, Inc. (2.87), less than Xenetic Biosciences, Inc. (4.56), less than Qualigen Therapeutics, Inc. (8.83), greater than Soligenix, Inc. (1.47),

Build a custom stock screener for Calidi Biotherapeutics, Inc. (CLDI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Calidi Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Calidi Biotherapeutics, Inc. (CLDI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Calidi Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.